The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
Abstract
Objective: Parkinson's disease (PD) is a neurodegenerative condition that typically presents as a movement disorder but is known to be associated with variable degrees of cognitive impairment including dementia. We investigated the genetic basis of susceptibility to and cognitive heterogeneity of this disease. Methods: In 659 PD patients, 109 of which were followed up for 3.5 years from diagnosis, and 2,176 control subjects, we studied candidate genes involved in protein aggregation and inclusion body formation, the pathological hallmark of parkinsonism: microtubule‐associated protein tau (MAPT), glycogen synthase kinase‐3β (GSK3B), and α‐synuclein (SNCA). Results: We observed that cognitive decline and the development of PD dementia are strongly associated (p = 10−4) with the inversion polymorphism containing MAPT. We also found a novel synergistic interaction between the MAPT inversion polymorphism and the single nucleotide polymorphism rs356219 from the 3′ region of SNCA. In our data, carrying a risk genotype at either of these loci marginally increases the risk for development of PD, whereas carrying the combination of risk genotypes at both loci approximately doubles the risk for development of the disease (p = 3 × 10−6). Interpretation: Our data support the hypothesis that tau and α‐synuclein are involved in shared or converging pathways in the pathogenesis of PD, and suggest that the tau inversion influences the development of cognitive impairment and dementia in patients with idiopathic PD. These findings have potentially important implications for understanding the interface between tau and α‐synuclein pathways in neurodegenerative disorders and for unraveling the biological basis for cognitive impairment and dementia in PD. Ann Neurol 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Self-citationPedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135
Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans
Cordell, H. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2463 · Cited by 1,084
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 1×
“In vitro experiments have demonstrated that -synuclein is able to initiate tau fibrillization, after which -synuclein and tau synergistically promote fibrillization.(43) Our findings of an interaction between SNCA and MAPT increasing risk for idiopathic PD lend further support to the intersection of the tau and -synuc…”
BackgroundA common inversion under selection in Europeans
Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., Baker, A., Jonasdottir, A., Ingason, A., Gudnadottir, V. G., et al. (2005) · Nature Genetics · doi:10.1038/ng1508 · Cited by 828
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Self-citationDementia associated with Parkinson's disease
Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 685
High-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
Pittman, A. M., Myers, A. J., Abou-Sleiman, P., Fung, H. C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031377 · Cited by 272
Interface between tauopathies and synucleinopathies: A tale of two proteins
Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 263
Zhang, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 258
Myers, A. J., Pittman, A. M., Zhao, A. S., Rohrer, K., Kaleem, M., Marlowe, L., Lees, A., Leung, D., McKeith, I. G., Perry, R. H., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.018 · Cited by 255
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease
Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · neurogenetics · doi:10.1007/s10048-005-0020-2 · Cited by 242
Multiple regions of α‐synuclein are associated with Parkinson's disease
Mueller, J. C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T., & Gasser, T. (2005) · Annals of Neurology · doi:10.1002/ana.20438 · Cited by 234
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
Zabetian, C. P., Hutter, C. M., Factor, S. A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Kay, D. M., Yearout, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21157 · Cited by 165
Rademakers, R., Melquist, S., Cruts, M., Theuns, J., Del-Favero, J., Poorkaj, P., Baker, M., Sleegers, K., Crook, R., De Pooter, T., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi361 · Cited by 164 · cited 2×
“Both in PSP and PD, common subhaplotypes of the H1 lineage have been reported to differ in their effect on susceptibility to disease.(18,30,31) To explore this in our study population, we typed additional markers reported in the literature(15,18) or in HapMap (release #16) to tag H1 subhaplotypes: microsatellites DG17…”
BackgroundResultTau haplotypes regulate transcription and are associated with Parkinson's disease
Kwok, J. B. J., Teber, E. T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G. D., Buchanan, D. D., Silburn, P. A., & Schofield, P. R. (2004) · Annals of Neurology · doi:10.1002/ana.10826 · Cited by 159
Linkage Disequilibrium and Association of MAPT H1 in Parkinson Disease
Skipper, L., Wilkes, K., Toft, M., Baker, M., Lincoln, S., Hulihan, M., Ross, O. A., Hutton, M., Aasly, J., & Farrer, M. (2004) · The American Journal of Human Genetics · doi:10.1086/424492 · Cited by 158
Haplotype-specific expression of exon 10 at the human MAPT locus
Caffrey, T. M., Joachim, C. L., Paracchini, S., Esiri, M. M., & Wade‐Martins, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl429 · Cited by 156
Tau gene and Parkinson's disease: a case-control study and meta-analysis
Healy, D. G., Abou-Sleiman, P. M., Lees, A. J., Casas, J. P., Quinn, N., Bhatia, K., Hingorani, A. D., & Wood, N. W. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.026203 · Cited by 127
Elbaz, A., Nelson, L. M., Payami, H., Ioannidis, J. P. A., Fiske, B. K., Annesi, G., Belin, A. C., Factor, S. A., Ferrarese, C., Hadjigeorgiou, G. M., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70579-8 · Cited by 84
Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients
Berg, D., Niwar, M., Maaß, S., Zimprich, A. A., Möller, J. C., Wüllner, U., Schmitz‐Hübsch, T., Klein, C., Tan, E., Schöls, L. J., et al. (2005) · Movement Disorders · doi:10.1002/mds.20504 · Cited by 75
Phenotypic associations of tau and ApoE in Parkinson's disease
Papapetropoulos, S., Farrer, M. J., Stone, J. T., Milkovic, N. M., Ross, O. A., Calvo, L., McQuorquodale, D., & Mash, D. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.008 · Cited by 59
Genomewide Association, Parkinson Disease, and PARK10
Farrer, M. J., Haugarvoll, K., Ross, O. A., Stone, J. T., Milkovic, N. M., Cobb, S. A., Whittle, A. J., Lincoln, S., Hulihan, M., Heckman, M. G., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504728 · Cited by 56
Conflicting Results Regarding the Semaphorin Gene (SEMA5A) and the Risk for Parkinson Disease
Clarimón, J., Scholz, S. W., Fung, H., Hardy, J., Eerola, J., Hellström, O., Chen, C., Wu, Y., Tienari, P. J., & Singleton, A. (2006) · The American Journal of Human Genetics · doi:10.1086/504727 · Cited by 54
Interaction of α‐synuclein and tau genotypes in Parkinson's disease
Mamah, C., Lesnick, T. G., Lincoln, S., Strain, K. J., de Andrade, M., Bower, J. H., Ahlskog, J. E., Rocca, W. A., Farrer, M. J., & Maraganore, D. M. (2005) · Annals of Neurology · doi:10.1002/ana.20387 · Cited by 47
Goris, A., Williams‐Gray, C. H., Foltynie, T., Compston, D. A. S., Barker, R., & Sawcer, S. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504726 · Cited by 46
Self-citationLi, Y., Rowland, C. M., Schrodi, S. J., Laird, W., Tacey, K. M., Ross, D. A., Leong, D. U., Catanese, J. J., Sninsky, J. J., & Grupe, A. (2006) · The American Journal of Human Genetics · doi:10.1086/504725 · Cited by 42
Molecular genetic pathways in Parkinson's disease: a review
Jain, S., Wood, N. W., & Healy, D. G. (2005) · Clinical Science · doi:10.1042/cs20050106 · Cited by 42
Fung, H., Xiromerisiou, G., Gibbs, J. R., Wu, Y., Eerola, J., Gourbali, V., Hellström, O., Chen, C. M., Duckworth, J., Papadimitriou, A., et al. (2006) · Neurodegenerative Diseases · doi:10.1159/000097301 · Cited by 42
Clark, L. N., Levy, G., Tang, M.-X., Mejia‐Santana, H., Ciappa, A., Tycko, B., COTE, L. J., Louis, E. D., Mayeux, R. P., & Marder, K. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00635-9 · Cited by 30
Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease
Lévecque, C., Elbaz, A., Clavel, J., Vidal, J. S., Amouyel, P., Alpérovitch, A., Tzourio, C., & Chartier-Harlin, M. C. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.015750 · Cited by 28
Association of the Tau haplotype with Parkinson's disease in the Greek population
Fidani, L., Kalinderi, K., Bostantjopoulou, S., Clarimón, J., Goulas, A., Katsarou, Z., Hardy, J., & Kotsis, A. (2006) · Movement Disorders · doi:10.1002/mds.20864 · Cited by 26
Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population
Pepłońska, B., Żekanowski, C., Religa, D., Czyźewski, K., Styczyńska, M., Pfeffer, A., Gabryelewicz, T., Gołębiowski, M., Łuczywek, E., Wasiak, B., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00788-2 · Cited by 23
Johansson, A., Zetterberg, H., Håkansson, A. S., Nissbrandt, H., & Blennow, K. (2005) · Neurodegenerative Diseases · doi:10.1159/000086428 · Cited by 23
No evidence for association of a European-specific chromosome 17 inversion with multiple sclerosis
Goris, A., Maranian, M. J., Walton, A., Yeo, T. W., Ban, M., Gray, J., Compston, A., & Sawcer, S. J. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201665 · Cited by 9
Self-citation
Cited by
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Self-citationParkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Self-citation
Metadata
- Authors
- Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., Chinnery, P. F., Barker, R. A., & Sawcer, S. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-08
- Volume
- 62
- Issue
- 2
- Pages
- 145-153
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2064233040
- Cited by
- 270
- References
- 40
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.